DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 74 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

Cineline India Limited — Reply to Clarification- Financial results

NSE 3 hrs ago·2 Sept 2026, 9:46 am

Cineline India

Cineline India Limited has submitted a clarification to the stock exchanges regarding its financial results for the quarter ended June 30, 2026. The company was asked to provide details under SEBI's Regulation 33, which mandates listed firms to disclose specific financial information to the public.

This disclosure is a routine regulatory requirement designed to ensure transparency and keep investors informed about the company's performance. While the company has now responded to the query, the specific content of the clarification was not provided in the update.

Investors should wait for the full financial statements to be released. It is important to review the detailed earnings report to understand the company's actual performance and future outlook before making any investment decisions.